- Phathom Pharmaceuticals press release (NASDAQ:PHAT): Q2 GAAP EPS of -$0.84 beats by $0.14.
- As of June 30, 2023, cash and cash equivalents were $248.8 million.
Phathom Pharmaceuticals GAAP EPS of -$0.84 beats by $0.14
Recommended For You
More Trending News
About PHAT Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PHAT | - | - |
| Phathom Pharmaceuticals, Inc. | ||